SoftOx Solutions AS (OSL:SOFTX) EBITDA Margin %: -83.45% (As of Dec. 2025)

What is SoftOx Solutions AS EBITDA Margin %?

SoftOx Solutions AS OSL:SOFTX EBITDA Margin % is -83.45% as of Dec. 2025. Among 935 Biotechnology companies, SoftOx Solutions AS ranks better than 51.66% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. SoftOx Solutions AS's EBITDA for the three months ended in Dec. 2025 was kr-3.02 Mil. SoftOx Solutions AS's Revenue for the three months ended in Dec. 2025 was kr3.61 Mil. Therefore, SoftOx Solutions AS's EBITDA margin for the quarter that ended in Dec. 2025 was -83.45%.

SoftOx Solutions AS (OSL:SOFTX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

SoftOx Solutions AS EBITDA Margin % Related Terms

SoftOx Solutions AS EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for SoftOx Solutions AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SoftOx Solutions AS EBITDA Margin % Chart

SoftOx Solutions AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBITDA Margin %

Get a 7-Day Free Trial

0.00

SoftOx Solutions AS Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
EBITDA Margin %	Get a 7-Day Free Trial															36.69	64.21	-58.31	-105.92	-83.45

OSL:SOFTX vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, SoftOx Solutions AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SoftOx Solutions AS EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SoftOx Solutions AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where SoftOx Solutions AS's EBITDA Margin % falls into.

Save Embed

SoftOx Solutions AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

SoftOx Solutions AS's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-8.18	/	0
	=	%

SoftOx Solutions AS's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-3.015	/	3.613
	=	-83.45 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -83.45% mean?

SoftOx Solutions AS (OSL:SOFTX) has a EBITDA Margin % of -83.45% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SoftOx Solutions AS and its competitors. According to the industry distribution chart, SoftOx Solutions AS ranks #452 out of 935 companies in the Biotechnology industry, placing it in the top 48.3%.

Is SoftOx Solutions AS's EBITDA Margin % too high?

SoftOx Solutions AS's current EBITDA Margin % is -83.45%. Based on the distribution chart, SoftOx Solutions AS ranks #452 out of 935 companies in the Biotechnology industry, which is above the industry midpoint.

How does SoftOx Solutions AS's EBITDA Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, SoftOx Solutions AS ranks #452 out of 935 companies for EBITDA Margin %. This puts SoftOx Solutions AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Biotechnology company?

A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SoftOx Solutions AS and its competitors. SoftOx Solutions AS's current EBITDA Margin % is -83.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is SoftOx Solutions AS stock overvalued right now?

SoftOx Solutions AS (OSL:SOFTX) has a current EBITDA Margin % of -83.45%. The current EBITDA Margin % is -83.45%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For SoftOx Solutions AS (OSL:SOFTX), the current EBITDA Margin % is -83.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SoftOx Solutions AS Business Description

Industry Healthcare Biotechnology

Comparable Companies OSL:ONCIN OSL:ZLNA OSL:EXTX OSL:ABS OSL:ABTEC OSL:LYTIX OSL:AZT OSL:NYKD VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX

Other Exchanges 6FV:Germany

Address Fridtjof Nansens vei 16, Lysaker, NOR, 1366

Website https://www.sow.no

SoftOx Solutions AS is a clinical-stage pharmaceutical company. It offers antimicrobial solutions for Wound and Skin Care. It has developed an effective antimicrobial solution to combat biofilm, viral, and antimicrobial-resistant infections. The technology is based on extensive research and development in partnership with Nordic research institutes.